✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

CanSino Biologics Inc

Common Name
CanSino Biologics
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,134
Ticker
688185
Exchange
Shanghai Stock Exchange
Description
CanSino Biologics Inc. is a biotechnology company focused on developing, manufacturing, and commercializing high-quality vaccines for public health. Founded in Tianjin, China, the company is known for...

CanSino Biologics's Waste Data Preview

In 2025, CanSino Biologics conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2025202420232022-2019
Total Waste Generated
221.77a
301.31a
753.67a
Total Waste Recovered
N/AN/AN/A
Total Hazardous Waste Generated
170.77a
216.42a
573.43a
Non-Hazardous Waste Disposed
N/AN/AN/A
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind CanSino Biologics’s Waste Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. CanSino Biologics's ESG Report 2025

Insights into CanSino Biologics’s Generation of Hazardous and Non-Hazardous Waste

In 2025, CanSino Biologics generated a total of 222 metric tonnes of waste.a

Of this amount, 77% of CanSino Biologics's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.23% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a

CanSino Biologics’s Hazardous vs Non-Hazardous Waste Over Time

2023202420250200400600800tonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How CanSino Biologics reduced the environmental impact of its waste?

Since 2023, CanSino Biologics's total waste generation decreased by 70.57%, with an additional 26.4% decline in 2025, suggesting a consistent and deliberate effort to minimize waste generation at the source.a

Over the same period, the share of hazardous waste in CanSino Biologics's total output increased by 1.21%, including a further 7.21% rise in 2025, suggesting a troubling upward shift toward more environmentally harmful waste streams that could raise compliance costs and environmental risks.a

Overall, CanSino Biologics's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.a

Want Full Access to CanSino Biologics's Waste Management Dataset?
Start 30-Day Free Trial